2024 - Present
ArtCart+ Equine Study: Candidate Selection Phase
Evaluating an enhanced version of the Articular Cartilage Paste Graft (ArtCart) surgical technique in an equine joint model to improve cartilage regeneration and graft fixation, advance treatment for veterinary patients, and generate essential evidence for future human clinical improvements.
2023 - Present
ArtCart+ Characterization and Optimization Studies
Enhancing the Articular Cartilage Paste Graft (ArtCart) surgical technique, with support from the California Institute for Regenerative Medicine (CIRM), to improve graft fixation, cell viability, and cartilage regeneration with the goal of developing a one-step, affordable, and accessible OA treatment.
2022 - Present
Articular Cartilage Paste Graft (ArtCart) Augmentation with Alpha-Gal Nanoparticles
Investigating whether adding the Alpha-Gal sugar molecule to augment the Articular Cartilage Paste Graft (ArtCart) procedure can stimulate a stronger healing response and produce more effective cartilage regeneration in arthritic joints through a novel molecular approach.
2022 - Present
Characterization of Orthobiologic Injections
Comparing leading orthobiologic injections for joint pain and inflammation to determine which therapies provide the safest, most effective, and longest-lasting outcomes for patients with sports injuries and arthritis.
2022-Present
Longitudinal Patient Outcomes
Tracking long-term patient-reported outcomes across a range of orthopaedic procedures to understand how patients recover over time. This data has already led to peer-reviewed publications while helping SRF identify patterns, evaluate treatment results, and generate evidence to guide future research and improve patient care.
2024 - Present
Use of Testosterone to Reduce Post-Surgical Muscle Loss: Clinical Trial
Building on a completed 15-patient pilot demonstrating feasibility and safety, this study will test whether short-term, long-acting injectable testosterone can protect against muscle loss after knee surgery. MuscleSound, Inc. technology will provide detailed ultrasound assessments of muscle mass and health.